Principia Wealth Advisory’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.36K Buy
35
+8
+30% +$533 ﹤0.01% 545
2026
Q1
$1.7K Hold
27
– – ﹤0.01% 559
2025
Q4
$1.79K Buy
27
+6
+29% +$388 ﹤0.01% 490
2025
Q3
$1.41K Buy
21
+1
+5% +$79 ﹤0.01% 524
2025
Q2
$1.75K Buy
20
+11
+122% +$862 ﹤0.01% 419
2025
Q1
$602 Sell
9
-4
-31% -$326 ﹤0.01% 527
2024
Q4
$1.01K Buy
+13
New +$962 ﹤0.01% 364

Other funds holding DXCM

Principia Wealth Advisory's DXCM Position: Q2 2026 in Review

Principia Wealth Advisory increased its DexCom (DXCM) stake by 30% in Q2 2026, buying an estimated $533 and bringing the position to 35 shares worth $2.36K. The position accounts for ﹤0.01% of the portfolio, ranked #545.

Principia Wealth Advisory first reported a position in DXCM in Q4 2024 and has held it in 7 quarters since. 976 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Principia Wealth Advisory held 35 shares of DexCom worth $2.36K as of Q2 2026.
  • Principia Wealth Advisory bought 8 DexCom shares in Q2 2026, an estimated $533.
  • DexCom made up ﹤0.01% of Principia Wealth Advisory's portfolio in Q2 2026, its #545 holding.
  • Principia Wealth Advisory first reported a position in DexCom in Q4 2024 and has held it in 7 quarters since.
  • 976 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Principia Wealth Advisory's 13F filing for Q2 2026, filed 26 Aug 2026.